首页 | 本学科首页   官方微博 | 高级检索  
     

米氮平与帕罗西汀治疗抑郁症对照研究
引用本文:林卓毅,余英仪,陈永平. 米氮平与帕罗西汀治疗抑郁症对照研究[J]. 四川医学, 2005, 26(11): 1229-1230
作者姓名:林卓毅  余英仪  陈永平
作者单位:1. 广东省江门市新会区沙堤医院,广东,江门,529100
2. 中山大学附属第三医院,广东,中山,510630
摘    要:
目的评价米氮平与帕罗西汀治疗抑郁症的疗效和不良反应。方法将符合CCMD-5诊断标准的48例抑郁症住院和门诊患者,随机平分为两组,分别予米氮平和帕罗西汀治疗,疗程6周。用汉密尔顿抑郁量表(HAMD)、汉密尔顿焦虑量表(HAMA)、临床疗效总评量表的病情严重程度(CGI—SI)和不良反应量表(TESS)评定疗效和不良反应。结果米氮平与帕罗西汀对抑郁症疗效接近,但前者起效更快,不良反应少于后者。结论米氮平是一种安全、有效的新一代抗抑郁药,可作为治疗抑郁症的第一线药物使用。

关 键 词:抑郁症 治疗 米氮平 帕罗西汀
文章编号:1004-0501(2005)11-1229-02

A study of mirtazapine and paroxetine in the treatment of anxiety
Lin Zhuoyi,Yu Yingyu,Chen Yongping. A study of mirtazapine and paroxetine in the treatment of anxiety[J]. Sichuan Medical Journal, 2005, 26(11): 1229-1230
Authors:Lin Zhuoyi  Yu Yingyu  Chen Yongping
Affiliation:1. Shadi Hospital of Xinhui , Jiangmen City, Guangdong 529100, China ;2. The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou 510630, China
Abstract:
Objective To compare efficacy and side effects between mirtazapine and paroxetine in the treatment of depression.Methods 48 inpatients and outpatients with a diagnosis of depression according to CCMD-3 were involved in this study,they were randomly assigned to mirtazapine group(n=24) and paroxetine group(n=24)for 6 weeks.Effects and side reactions were evaluated with HAMD,HAMA,CGI-SI and TESS before and after the treatment.Results Findings indicated that efficacy of mirtazapine was similar to than of paroxetine,however mirtazapine took effect more quickly and its side effects were less than paroxetine.Conclusion Mirtazapine is an effective and safe antidepressant.It is suggested that mirtazapine could be used as a first-line antidepressant in the treatment of depression
Keywords:mirtazapine    paroxetine    depression
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号